2026 Labeled as a Transition Year for Mobileye (MBLY)

Mobileye Global (NASDAQ:MBLY) is one of the best Auto Parts stocks according to Hedge Funds.

On January 23, George Gianarikas from Canaccord Genuity reaffirmed his Buy rating for Mobileye Global (NASDAQ:MBLY). Although the analyst revised his price target estimate from $30 to $24, it still results in a lucrative upside potential of almost 159%.

Gianarikas did highlight certain areas that led to reservations regarding the company’s long-term earnings potential. These include a cycle of guidance cuts and perceived halts on next-generation OEM partnerships. Despite these issues, the analyst has a favorable outlook on the stock.

On January 23, Raymond James analyst Brian Gesuale maintained his Outperform rating on Mobileye Global (NASDAQ:MBLY) after the company announced its fourth-quarter results. He set a price target of $16, which yields an upside potential of almost 73%.

The company registered $446 million in revenues, which was an outperformance relative to expectations. It shipped 8.3 million systems at an average unit price of $50.80, yielding benefits from SuperVision products within the overall mix. Management has dubbed 2026 a transition year, and Raymond James expects some catalysts to emerge during the later stages of 2026.

Mobileye Global (NASDAQ:MBLY) develops advanced driver assistance systems (ADAS) and autonomous driving technologies (AV). It delivers end-to-end solutions comprising Base ADAS, Cloud-Enhanced ADAS, and Surround ADAS. It also offers safety features, including collision warning, lane departure warnings, headway monitoring, speed limit indicator, blind spot detection, and more.

While we acknowledge the potential of MBLY as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: 15 Most Promising Mid-Cap Healthcare Stocks Under $50 and 11 Most Promising Small-Cap Industrial Stocks Under $50.

Disclosure: None. This article is originally published at Insider Monkey.